Vitrification Yields Superior Efficiency of Human Cleavage-Stage Embryo Cryopreservation Versus Slow-Freezing

S. Xue,Q. Lyu,Q. Peng,S. Cao,Y. Zhou,Y. Kuang
DOI: https://doi.org/10.1016/j.fertnstert.2010.07.486
IF: 6.7
2010-01-01
Fertility and Sterility
Abstract:OBJECTIVE: Application of vitrification in human IVF programs has mainly focused on oocytes and blastocyst-stage embryos. This retrospective study compares the clinical outcome following vitrification or slow freezing of cleavage-stage human embryos at day 2 and 3.DESIGN: Retrospective analysis.MATERIALS AND METHODS: A total of 4196 embryos collected from patients undergoing 1621 treatment cycles were vitrified and 605 embryos from 122 cycles were slow frozen. For vitrification, home-made strawtop carrier system was performed and 15%(v/v) ethylene glycol (EG), 15%(v/v) Dimethylsulphoxide (DMSO) and 0.58M sucrose as the cryoprotectant.RESULTS: The survival rates of embryos on day 2 and day 3 in the vitrification group (96.6% and 97.1%, p<0.05 both) was significantly higher than the slow-freezing group (77.0% and 62.9%). The mean number of thawed embryos needed for one implantation for day2 embryos in the slow-freezing group (17.5) is 1.8 times (17.5/9.8) for that of the vitrification group (9.8). AS for day3 embryos, the mean number in the slow-freezing group (26.4) is 4.2 times (26.4/6.3) for that of the vitrification group (6.3).CONCLUSION: Vitrification is a simple, efficient method for human cleavage-stage embryo cryopreservation and represents a viable alternative to the conventional slow-freezing procedure. OBJECTIVE: Application of vitrification in human IVF programs has mainly focused on oocytes and blastocyst-stage embryos. This retrospective study compares the clinical outcome following vitrification or slow freezing of cleavage-stage human embryos at day 2 and 3. DESIGN: Retrospective analysis. MATERIALS AND METHODS: A total of 4196 embryos collected from patients undergoing 1621 treatment cycles were vitrified and 605 embryos from 122 cycles were slow frozen. For vitrification, home-made strawtop carrier system was performed and 15%(v/v) ethylene glycol (EG), 15%(v/v) Dimethylsulphoxide (DMSO) and 0.58M sucrose as the cryoprotectant. RESULTS: The survival rates of embryos on day 2 and day 3 in the vitrification group (96.6% and 97.1%, p<0.05 both) was significantly higher than the slow-freezing group (77.0% and 62.9%). The mean number of thawed embryos needed for one implantation for day2 embryos in the slow-freezing group (17.5) is 1.8 times (17.5/9.8) for that of the vitrification group (9.8). AS for day3 embryos, the mean number in the slow-freezing group (26.4) is 4.2 times (26.4/6.3) for that of the vitrification group (6.3). CONCLUSION: Vitrification is a simple, efficient method for human cleavage-stage embryo cryopreservation and represents a viable alternative to the conventional slow-freezing procedure.
What problem does this paper attempt to address?